BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11496913)

  • 1. Intravitreal antibiotics: the emergency kit.
    Cordovés L; Abreu A; Seal D; Barry P
    J Cataract Refract Surg; 2001 Jul; 27(7):971-2. PubMed ID: 11496913
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravitreal dexamethasone in the management of acute endophthalmitis: a comparative retrospective study.
    Moisseiev E; Abbassi S; Park SS
    Eur J Ophthalmol; 2017 Jan; 27(1):67-73. PubMed ID: 27646336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental pseudomonal posttraumatic endophthalmitis in a swine model. Treatment with ceftazidime, amikacin, and imipenem.
    Alfaro DV; Hudson SJ; Kasowski EJ; Barton CP; Brucker AJ; Lopez JD; Beverly DT; King LP
    Retina; 1997; 17(2):139-45. PubMed ID: 9143043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal vancomycin and amikacin versus intravenous imipenem in the treatment of experimental Staphylococcus aureus endophthalmitis.
    Engelbert M; Miño de Kaspar H; Thiel M; Grasbon T; Ta CN; Schulze-Schwering M; Klauss V; Kampik A
    Graefes Arch Clin Exp Ophthalmol; 2004 Apr; 242(4):313-20. PubMed ID: 14986007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macula toxicity after intravitreal amikacin.
    Seawright AA; Bourke RD; Cooling RJ
    Aust N Z J Ophthalmol; 1996 May; 24(2):143-6. PubMed ID: 9199746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of intravitreal piperacillin/tazobactam with ceftazidime in experimental Pseudomonas aeruginosa endophthalmitis.
    Ozkiriş A; Evereklioglu C; Akgün H; Eşel D; Caner F; Erkiliç K
    Exp Eye Res; 2005 Mar; 80(3):361-7. PubMed ID: 15721618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of bacterial isolates to vancomycin and ceftazidime from patients with endophthalmitis: Is there a need to change the empirical therapy in suspected bacterial endophthalmitis?
    Reddy AK; Reddy RR; Paruvelli MR; Ambatipudi S; Rani A; Lodhi SA; Reddy JM; Reddy KR; Pandey N; Videkar R; Sinha MK; Majji AB; Deb-Jorder N; Sahu AK; Myneni J; Abraham A
    Int Ophthalmol; 2015 Feb; 35(1):37-42. PubMed ID: 25384628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orbital cellulitis and endophthalmitis in pseudomonas septicemia.
    Luemsamran P; Pornpanich K; Vangveeravong S; Mekanandha P
    Orbit; 2008; 27(6):455-7. PubMed ID: 19085303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute endophthalmitis following intravitreal triamcinolone acetonide injection.
    Canakis C; Livir-Rallatos C; Zafirakis P; Livir-Rallatos G
    Am J Ophthalmol; 2004 Jun; 137(6):1158-9; author reply 1160-1. PubMed ID: 15183822
    [No Abstract]   [Full Text] [Related]  

  • 10. Pediatric endogenous bacterial endophthalmitis: case report and review of the literature.
    Chaudhry IA; Shamsi FA; Al-Dhibi H; Khan AO
    J AAPOS; 2006 Oct; 10(5):491-3. PubMed ID: 17070493
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibiotic susceptibility in Endophthalmitis Management Study and intravitreal antibiotic practice trend in India-EMS Report #5.
    Das T; Pandey S; Joseph J; Sheth J; Belenje A; Behera UC; Kapoor A; Pandya R; Dave VP
    Graefes Arch Clin Exp Ophthalmol; 2024 Jul; 262(7):2163-2169. PubMed ID: 38319381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin concentration in the vitreous after intravenous and intravitreal administration for postoperative endophthalmitis.
    Ferencz JR; Assia EI; Diamantstein L; Rubinstein E
    Arch Ophthalmol; 1999 Aug; 117(8):1023-7. PubMed ID: 10448744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinupristin/dalfopristin in vancomycin-resistant Staphylococcus aureus endophthalmitis.
    Stroh EM
    Arch Ophthalmol; 2012 Oct; 130(10):1323-4. PubMed ID: 23044949
    [No Abstract]   [Full Text] [Related]  

  • 14. Emerging Worldwide Antimicrobial Resistance, Antibiotic Stewardship and Alternative Intravitreal Agents for the Treatment of Endophthalmitis.
    Relhan N; Pathengay A; Schwartz SG; Flynn HW
    Retina; 2017 May; 37(5):811-818. PubMed ID: 28338559
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment.
    Bucher RS; Hall E; Reed DM; Richards JE; Johnson MW; Zacks DN
    Arch Ophthalmol; 2005 May; 123(5):649-53. PubMed ID: 15883284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy of intravitreal ceftazidime, imipenem, and amikacin in a swine model of posttraumatic Pseudomonas aeruginosa endophthalmitis.
    Ng EW; D'Amico DT
    Retina; 1997; 17(5):464-5. PubMed ID: 9355203
    [No Abstract]   [Full Text] [Related]  

  • 17. Persistently Vitreous Culture-Positive Exogenous Bacterial Endophthalmitis.
    Leung EH; Kuriyan AE; Flynn HW; Miller D; Huang LC
    Am J Ophthalmol; 2016 May; 165():16-22. PubMed ID: 26921804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precipitation of Vancomycin and Ceftazidime on Intravitreal Injection in Endophthalmitis Patients.
    Noh GM; Nam KY; Lee SU; Lee SJ
    Korean J Ophthalmol; 2019 Jun; 33(3):296-297. PubMed ID: 31179663
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative intravitreal antibiotic therapy for experimental Enterococcus faecalis endophthalmitis.
    Choi S; Hahn TW; Osterhout G; O'Brien TP
    Arch Ophthalmol; 1996 Jan; 114(1):61-5. PubMed ID: 8540852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceftazidime or amikacin: choice of intravitreal antimicrobials in the treatment of postoperative endophthalmitis.
    Doft BH; Barza M
    Arch Ophthalmol; 1994 Jan; 112(1):17-8. PubMed ID: 8285881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.